Matches in Nanopublications for { <http://bio2rdf.org/drugbank:DB05198> ?p ?o ?g. }
Showing items 1 to 12 of
12
with 100 items per page.
- drugbank:DB05198 type drugbank_vocabulary:Drug assertion.
- drugbank:DB05198 label "CYC116 [drugbank:DB05198]" assertion.
- drugbank:DB05198 seeAlso DB05198 assertion.
- drugbank:DB05198 description "CYC116 is a novel anticancer compound with a unique target profile involving both cell cycle and angiogenesis inhibition mechanisms. In preclinical studies, CYC116 has demonstrated antitumor activity in both solid tumors and hematological cancers. Cyclacel's small molecule investigational drug, CYC116, is the third orally-available Cyclacel drug to enter development, which demonstrated anticancer activity with a mechanism consistent with inhibition of Aurora kinase." assertion.
- drugbank:DB05198 identifier "drugbank:DB05198" assertion.
- drugbank:DB05198 title "CYC116" assertion.
- drugbank:DB05198 drugbank_vocabulary:x-cas cas: assertion.
- drugbank:DB05198 drugbank_vocabulary:drugbank-id "DB05198" assertion.
- drugbank:DB05198 bio2rdf_vocabulary:x-identifiers.org DB05198 assertion.
- drugbank:DB05198 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB05198" assertion.
- drugbank:DB05198 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB05198 bio2rdf_vocabulary:identifier "DB05198" assertion.